Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Sigyn Therapeutics, Inc. | StockGist | StockGist

Companies
SIGY
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings SIGYSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Sigyn Therapeutics, Inc.

Filed Jan 14, 2026

Accepted Jan 13, 2026, 7:00 PM ET

CIK 0001642159

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

9.99%

Shares Owned

84,608

Reporting Person

Sigyn Therapeutics, Inc.

Person Type

CO

CUSIP: 82674U205

Key Facts

% of Class

9.99%

Shares Owned

84,608

Recent Filings

Sigyn Therapeutics, Inc.1 months ago

Sigyn Therapeutics, Inc.4 months ago

Sigyn Therapeutics, Inc.7 months ago

Sigyn Therapeutics, Inc.7 months ago

Sigyn Therapeutics, Inc.10 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice